M Schattenkirchner

Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components

M. Dougados, B. Combe, Alain Cantagrel et al. · Annals of the Rheumatic Diseases · 1999 · 263 citations · Full text

A single dose, placebo controlled study of the fully human anti-tumor necrosis factor-alpha antibody adalimumab (D2E7) in patients with rheumatoid arthritis.

Alfons A den Broeder, Leo van de Putte, Rolf Rau et al. · PubMed · 2002 · 195 citations

Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis

Matthias Mack, Hilke Br�hl, Rudi Gruber et al. · Arthritis & Rheumatism · 1999 · 136 citations · Full text

Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administration

Christian Reiter, Bahram Kakavand, Ernst Peter Rieber et al. · Arthritis & Rheumatism · 1991 · 136 citations

Clinical Immunology, Cd4+ Cells, Immunology +17

The efficacy and safety of leflunomide in patients with active rheumatoid arthritis: A five‐year followup study

Joachim R. Kalden, M Schattenkirchner, H. Sörensen et al. · Arthritis & Rheumatism · 2003 · 132 citations